Universal DX is a bioinformatics and multi-omics company dedicated to revolutionizing the field of cancer detection and treatment. With a vision of a future where cancer is curable, Universal DX employs cutting-edge technologies and machine learning models to decipher the signals of the disease and detect it in its earliest stages. Their flagship product is a multicancer platform that utilizes minimally-invasive, blood-based solutions for the early detection of various types of cancers.

Starting with colorectal cancer, Universal DX is building a comprehensive platform capable of identifying unique DNA regions associated with different cancers. To achieve their ambitious goals, Universal DX collaborates with a network of world-class R&D partners and has assembled a renowned Scientific Advisory Board consisting of leading oncologists, gastroenterologists, scientists, and business experts. With offices in Seville, Madrid, Ljubljana, and Cambridge, Universal DX is actively recruiting talented individuals who are passionate about making a difference in the fight against cancer.

Join Universal DX and be a part of their mission to create a future where cancer is curable